Meningiomas are the most common primary brain tumor in adults, however, in comparison to other tumors they are extremely understudied. The International Consortium on Meningiomas, under the leadership of Dr. Gelareh Zadeh, has been formed in order to increase awareness and conduct high quality cutting-edge research on these highly understudied tumors. The Consortium has representatives from 29 institutions across 4 continents with expertise ranging across the fields of neurosurgery, neuropathology, neuro-oncology, neuro-radiology, radiation oncology, molecular/translational biology, bioinformatics, and statistics/epidemiology. The Consortium meets regularly by teleconference as well as face-to-face meetings to discuss and present progression on ongoing projects. Examples of the Consortium’s prior publications are listed here.
If you have a question for the Consortium or are interested in joining please e-mail: gelareh.zadeh@uhn.ca
The Society for Neuro-Oncology and the International Consortium on Meningiomas, in partnership with the National Cancer Institute and the Neurosurgical Atlas, are pleased to announce a special one-day conference, 2021 Meningioma Day, Current management strategies and future directions, on May 15, 2021, from 8:20 a.m.-4:15 p.m. EST.
